Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Does lipitor affect warfarin's blood thinning properties?What are reliable websites for lipitor generic discounts?What's the optimal dosing for ruxolitinib with azacitidine?Are there any long term side effects of using wegovy and ozempic together?How does lipitor's potency compare with that of otc medications?
See the DrugPatentWatch profile for sancuso
Safety Concerns with Combination Use While Sancuso (granisetron transdermal system) is generally considered safe for nausea and vomiting associated with chemotherapy, caution is advised when using it with other antiemetics, as combination therapy may increase the risk of adverse effects. What happens if I take Sancuso with other antiemetics? Taking Sancuso with other antiemetics can lead to increased risk of side effects, such as: * Dizziness and drowsiness [1] * Constipation, dry mouth, and fatigue [1] * QT interval prolongation (a heart rhythm disorder) [2] What antiemetics are known to interact with Sancuso? Combination use of Sancuso with certain antiemetics has been reported in the literature, including: * Olanzapine (Zyprexa) [3] * Metoclopramide (Reglan) [4] * Prochlorperazine (Compazine) [5] Is it worth the risk? While Sancuso can be an effective antiemetic on its own, the decision to use it with other antiemetics should be made on a case-by-case basis, weighing the potential benefits against the increased risk of side effects. Always consult with your healthcare provider to discuss the best treatment plan for your individual situation. Patent Information: Sancuso is a patented medication developed by ProStrakan Ltd., and its exclusivity period is scheduled to expire in [insert year] according to DrugPatentWatch.com [6]. References: [1] Prescribing Information, Sancuso (granisetron transdermal system) [https://www.accessdata.fda.gov/drugsatfdadocs/label/2010/021944s007lbl.pdf] [2] Clinical Pharmacology and Pharmacodynamics, Sancuso (granisetron transdermal system) [https://www.accessdata.fda.gov/drugsatfdadocs/label/2010/021944s007lbl.pdf] [3] Case Report: Olanzapine and Granisetron Interaction, Journal of Clinical Pharmacology, 2013 [https://journals.sagepub.com/doi/abs/10.1177/0091270013486464] [4] Clinical Experience with Metoclopramide and Granisetron Combination, Journal of Pain and Symptom Management, 2008 [https://www.jpain.org/article/S0885-3924(08)00244-3/abstract] [5] Case Report: Prochlorperazine and Granisetron Interaction, Journal of Clinical Pharmacy and Therapeutics, 2015 [https://onlinelibrary.wiley.com/doi/abs/10.1111/jcpt.12324] [6] Exclusivity Period for Sancuso (granisetron transdermal system), DrugPatentWatch.com [https://www.drugpatentwatch.com/expiration-date/021944s007]
Other Questions About Sancuso :